---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-297085"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2026-07-07T14:38:16+00:00"
generated_at: "2026-07-07T14:42:12.424040+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Semnur signs binding term sheet for $100M strategic investment from iHolding Group at $10/share

## Summary
- iHolding to purchase $100M of newly issued common stock at $10/share (~10M shares).
- Proceeds to fund SEMDEXA Phase 3 program, product development, acquisitions, working capital.
- Investment subject to due diligence, definitive agreements, board/stockholder/regulatory approvals.
- Semnur is a majority-owned subsidiary of Scilex Holding Company.
- No assurance of consummation; risks of termination or litigation.

## SEC filing metadata
- accession: 0001193125-26-297085
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2026-07-07T14:38:16+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000119312526297085/0001193125-26-297085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000119312526297085/smnr-20260703.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-297085
- JSON: https://secwatch.observer/filing/0001193125-26-297085.json
- Plain text: https://secwatch.observer/filing/0001193125-26-297085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.